NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Human Metabolomics Institute, Inc.

Human Metabolomics Institute, Inc.

Private
ShenzhenHealthcare & Life Scienceshttps://hmibiotech.com/sc/

Last Round

Series A++

Aug 28, 2025

Total Funding Raised

$4.35M

Company Overview

Human Metabolomics Institute, Inc. is a biotechnology company that develops and provides mass spectrometry-based molecular diagnostic solutions, including in-vitro diagnostic kits, AI-enabled auxiliary software, and metabolomics research services.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Devices, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

metabolomicsin-vitro diagnosticIVDmass spectrometryprecision medicineclinical decision supportbiomarker discoverymetabolomics-on-a-chipmedical AIchronic disease screeningmolecular diagnosticshealthcare analyticslab-on-a-chipAI diagnosticsbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Human Metabolomics Institute, Inc. Comps

Public and private peers based on sector, stage, and business model.

Human Metabolomics Institute, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Human Metabolomics Institute, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A++Aug 28, 2025
Series BJan 28, 2025
Series AAug 1, 2021
AngelAug 1, 2017

Human Metabolomics Institute, Inc. Investors

Notable investors and investment history

Human Metabolomics Institute, Inc. investors
InvestorRounds
Hyfinity InvestmentsAngel, Series A++
深圳市投控东海投资有限公司Series A
Hongli Innovation InvestmentAngel

Human Metabolomics Institute, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Human Metabolomics Institute, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Human Metabolomics Institute, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShenzhen
Year Founded2017
Last FundingAug 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.